HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wolfgang Eiermann Selected Research

Heart Failure

10/2011Adjuvant trastuzumab in HER2-positive breast cancer.
1/2010Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wolfgang Eiermann Research Topics

Disease

58Breast Neoplasms (Breast Cancer)
01/2022 - 11/2002
25Neoplasms (Cancer)
01/2020 - 05/2004
3Fatigue
02/2020 - 04/2011
3Disease Progression
01/2018 - 05/2004
3Inflammatory Breast Neoplasms
05/2014 - 01/2010
3Pathologic Complete Response
01/2014 - 12/2005
2Cardiotoxicity
01/2022 - 10/2011
2Nausea
02/2020 - 08/2005
2Anemia
02/2020 - 01/2018
2Triple Negative Breast Neoplasms
02/2020 - 07/2014
2Ductal Carcinoma
01/2020 - 02/2014
2Wounds and Injuries (Trauma)
01/2020 - 02/2014
2Carcinoma (Carcinomatosis)
10/2017 - 04/2013
2Venous Thrombosis (Deep-Vein Thrombosis)
02/2016 - 05/2014
2Heart Failure
10/2011 - 01/2010
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Neutropenia
02/2020
1Alopecia (Baldness)
02/2020
1Stroke (Strokes)
02/2016
1Spasm (Spasms)
02/2016
1Noninfiltrating Intraductal Carcinoma (DCIS)
02/2016
1Thrombosis (Thrombus)
05/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014
1Leukemia
10/2011
1Colorectal Neoplasms (Colorectal Cancer)
07/2011
1Headache (Headaches)
07/2011
1Pain (Aches)
07/2011
1Arthralgia (Joint Pain)
07/2011
1Hypertension (High Blood Pressure)
04/2011
1Lobular Carcinoma
07/2010

Drug/Important Bio-Agent (IBA)

19Trastuzumab (Herceptin)FDA Link
01/2022 - 12/2003
11Hormones (Hormone)IBA
02/2020 - 11/2005
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015 - 12/2005
9AnthracyclinesIBA
01/2022 - 01/2005
8taxaneIBA
11/2019 - 01/2005
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 12/2003
7Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 12/2003
7Methotrexate (Mexate)FDA LinkGeneric
10/2015 - 12/2005
7Fluorouracil (Carac)FDA LinkGeneric
10/2015 - 12/2005
6ErbB Receptors (EGF Receptor)IBA
02/2020 - 01/2005
6Docetaxel (Taxotere)FDA Link
08/2013 - 05/2004
5human ERBB2 proteinIBA
11/2019 - 05/2012
5TamoxifenFDA LinkGeneric
02/2016 - 11/2002
4Capecitabine (Xeloda)FDA Link
02/2020 - 08/2013
4Ado-Trastuzumab EmtansineIBA
11/2019 - 01/2017
4pertuzumabIBA
11/2019 - 01/2017
4Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2013
4Anastrozole (Arimidex)FDA LinkGeneric
02/2016 - 11/2002
3Vinorelbine (Navelbine)FDA LinkGeneric
02/2020 - 08/2013
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
3Phenobarbital (Luminal)FDA Link
10/2017 - 05/2012
3Epirubicin (Ellence)FDA LinkGeneric
10/2015 - 11/2007
3Pharmaceutical PreparationsIBA
05/2014 - 01/2005
3Biomarkers (Surrogate Marker)IBA
12/2012 - 10/2008
3Estrogen ReceptorsIBA
12/2012 - 12/2005
3Carboplatin (JM8)FDA LinkGeneric
10/2011 - 05/2004
3Goserelin (Zoladex)FDA Link
07/2011 - 08/2006
2talazoparibIBA
02/2020 - 01/2018
2eribulinFDA Link
02/2020 - 01/2018
2Poly Adenosine Diphosphate RiboseIBA
02/2020 - 01/2018
2GemcitabineFDA Link
02/2020 - 01/2018
2Aromatase InhibitorsIBA
02/2016 - 11/2002
2ParaffinIBA
01/2014 - 12/2012
2Estrogens (Estrogen)FDA Link
12/2012 - 01/2005
2Letrozole (Femara)FDA LinkGeneric
10/2008 - 11/2002
1Codon (Codons)IBA
01/2022
1Biological ProductsIBA
01/2021
1cabazitaxelFDA Link
10/2017
1130-nm albumin-bound paclitaxelIBA
10/2015
1IceIBA
10/2015
1RNA (Ribonucleic Acid)IBA
01/2014
1Formaldehyde (Formol)FDA Link
01/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1Phosphotransferases (Kinase)IBA
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1Tyrosine (L-Tyrosine)FDA Link
09/2013
1Oncostatin MIBA
04/2013
1LigandsIBA
04/2013
1EpiregulinIBA
04/2013
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
04/2013
1Progesterone Receptors (Progesterone Receptor)IBA
12/2012
1Fulvestrant (Faslodex)FDA Link
06/2012
1Alkylating AgentsIBA
10/2011
1Taxoids (Taxanes)IBA
10/2011
1Zoledronic Acid (Zometa)FDA Link
07/2011
1motesanib diphosphateIBA
04/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
1Bevacizumab (Avastin)FDA Link
04/2011
1Type II DNA Topoisomerases (Topoisomerase II)IBA
03/2011
1EnzymesIBA
03/2011
1Diphosphonates (Bisphosphonates)IBA
04/2010

Therapy/Procedure

22Therapeutics
01/2022 - 11/2002
17Drug Therapy (Chemotherapy)
01/2022 - 05/2004
12Neoadjuvant Therapy
10/2017 - 04/2006
6Segmental Mastectomy (Lumpectomy)
01/2021 - 07/2010
6Radiotherapy
01/2021 - 07/2010
5Adjuvant Chemotherapy
01/2019 - 10/2008
1Mastectomy (Mammectomy)
01/2020
1Adjuvant Radiotherapy
01/2020
1Contraindications
02/2016